Dose response of dexmedetomidine‑induced resistance to hypoxia in mice

Pan,Wanying; Hua,Xiaoxiao; Wang,Yueting; Guo,Ruixian; Chen,Jingfu; Mo,Liqiu

doi:10.3892/mmr.2016.5588

Dose response of dexmedetomidine‑induced resistance to hypoxia in mice

Authors:
- Wanying Pan
- Xiaoxiao Hua
- Yueting Wang
- Ruixian Guo
- Jingfu Chen
- Liqiu Mo
View Affiliations

Affiliations: Department of Anesthesiology, The First Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Physiology, Zhongshan Medical College, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Cardiovasology and Cardiac Care Unit, Huangpu Division of The First Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: August 4, 2016 https://doi.org/10.3892/mmr.2016.5588
Pages: 3237-3242

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tolerance to hypoxia can be induced by reducing oxygen consumption. Dexmedetomidine (DEX) decreases locomotor activity and induces bradycardia and hypothermia in mice. The present study examined the hypothesis that DEX improves hypoxia tolerance in mice. Adult mice received an intraperitoneal injection of 1, 5, 10, 20, 40, 80, 160 or 320 µg/kg DEX, 20 mg/kg propranolol or saline. Acute hypoxic conditions were induced by placing the mice in a limited enclosed container with soda lime. Core body temperature (CBT) and heart rate (HR) were measured prior to and 30 min after drug administration. Survival time was monitored in the sealed container. Survival times (mean ± standard deviation) of mice in the saline, 1, 5, 10, 20, 40, 80, 160 and 320 µg/kg DEX, and the 20 mg/kg propranolol groups were 22.4±1.1, 23.4±1.1, 26.0±0.9, 36.9±5.2, 42.4±2.9, 43.2±2.3, 58.2±4.2, 80.5±4.0, 79.2±6.0, and 38.2±2.8 min, respectively. Pretreatment with propranolol and 10, 20, 40, 80, 160 or 320 µg/kg DEX, but not 1 or 5 µg/kg, significantly prolonged survival time compared with saline‑injected mice (P<0.05 or P<0.01). CBT and HR decreased in a similar manner. The correlation coefficients between survival time and CBT, and survival time and HR were ‑0.802 and ‑0.726, respectively. Thus, DEX dose‑dependently enhances hypoxia tolerance in mice. In conclusion, it is suggested that DEX may be used in clinical practice as a novel protective agent for organs and tissues during hypoxic injury.

View Figures

View References

1	Biorck G, Johansson B and Schmid H: Reactions of hedgehogs, hibernating and non-hibernating, to the inhalation of oxygen, carbon dioxide and nitrogen. Acta Physiol Scand. 37:71–83. 1956. View Article : Google Scholar : PubMed/NCBI
2	Frerichs KU, Kennedy C, Sokoloff L and Hallenbeck JM: Local cerebral blood flow during hibernation, a model of natural tolerance to 'cerebral ischemia'. J Cereb Blood Flow Metab. 14:193–205. 1994. View Article : Google Scholar : PubMed/NCBI
3	Ramirez JM, Folkow LP and Blix AS: Hypoxia tolerance in mammals and birds: From the wilderness to the clinic. Annu Rev Physiol. 69:113–143. 2007. View Article : Google Scholar
4	Blackstone E, Morrison M and Roth MB: H2S induces a suspended animation-like state in mice. Science. 308:5182005. View Article : Google Scholar : PubMed/NCBI
5	Nystul TG and Roth MB: Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci USA. 101:9133–9136. 2004. View Article : Google Scholar : PubMed/NCBI
6	Kapinya KJ, Löwl D, Fütterer C, Maurer M, Waschke KF, Isaev NK and Dirnagl U: Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 33:1889–1898. 2002. View Article : Google Scholar : PubMed/NCBI
7	Ding Q, Wang Q, Deng J, Gu Q, Hu S, Li Y, Su B, Zeng Y and Xiong L: Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits. Anesth Analg. 109:1263–1272. 2009. View Article : Google Scholar : PubMed/NCBI
8	Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L and Roosen K: Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study. Crit Care Med. 38:1284–1290. 2010. View Article : Google Scholar : PubMed/NCBI
9	Zheng H, Dong Y, Xu Z, Crosby G, Culley DJ, Zhang Y and Xie Z: Sevoflurane anesthesia in pregnant mice induces neurotoxicity in fetal and offspring mice. Anesthesiology. 118:516–526. 2013. View Article : Google Scholar : PubMed/NCBI
10	Wester maier T, Zausinger S, Baethmann A and Schmid-Elsaesser R: Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochir (Wien). 147:525–532; discussion 532. 2005. View Article : Google Scholar
11	Kamibayashi T and Maze M: Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 93:1345–1349. 2000. View Article : Google Scholar : PubMed/NCBI
12	Jolkkonen J, Puurunen K, Koistinaho J, Kauppinen R, Haapalinna A, Nieminen L and Sivenius J: Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 372:31–36. 1999. View Article : Google Scholar : PubMed/NCBI
13	Kuhmonen J, Pokorný J, Miettinen R, Haapalinna A, Jolkkonen J, Riekkinen P Sr and Sivenius J: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology. 87:371–377. 1997. View Article : Google Scholar : PubMed/NCBI
14	Maier C, Steinberg GK, Sun GH, Zhi GT and Maze M: Neuropro-tection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology. 79:306–312. 1993. View Article : Google Scholar : PubMed/NCBI
15	Ibacache M, Sanchez G, Pedrozo Z, Galvez F, Humeres C, Echevarria G, Duaso J, Hassi M, Garcia L, Díaz-Araya G and Lavandero S: Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochim Biophys Acta. 1822:537–545. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wijeysundera DN, Naik JS and Beattie WS: Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med. 114:742–752. 2003. View Article : Google Scholar : PubMed/NCBI
17	Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, Xia P, Maze M and Ma D: Dexmedetomidine provides reno-protection against ischemia-reperfusion injury in mice. Crit Care. 15:R1532011. View Article : Google Scholar
18	Si Y, Bao H, Han L, Shi H, Zhang Y, Xu L, Liu C, Wang J, Yang X, Vohra A and Ma D: Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation. J Transl Med. 11:1412013. View Article : Google Scholar : PubMed/NCBI
19	Zhang XY, Liu ZM, Wen SH, Li YS, Li Y, Yao X, Huang WQ and Liu KX: Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology. 116:1035–1046. 2012. View Article : Google Scholar : PubMed/NCBI
20	Wang ZX, Huang CY, Hua YP, Huang WQ, Deng LH and Liu KX: Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: A randomized controlled trial. Br J Anaesth. 112:1055–1064. 2014. View Article : Google Scholar : PubMed/NCBI
21	Lähdesmäki J, Sallinen J, MacDonald E, Sirviö J and Scheinin M: Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropharmacology. 44:882–892. 2003. View Article : Google Scholar : PubMed/NCBI
22	Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh GS, et al: Genetic alteration of alpha 2C-adrenoceptor expression in mice: Influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. Mol Pharmacol. 51:36–46. 1997.PubMed/NCBI
23	Shen ZB, Yin YQ, Tang CP, Yan CY, Chen C and Guo LB: Phar-macodynamic screening and simulation study of anti-hypoxia active fraction of xiangdan injection. J Ethnopharmacol. 127:103–107. 2010. View Article : Google Scholar
24	Salmenperä MT, Szlam F and Hug CC Jr: Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology. 80:837–846. 1994. View Article : Google Scholar : PubMed/NCBI
25	Hogue CW Jr, Talke P, Stein PK, Richardson C, Domitrovich PP and Sessler DI: Autonomic nervous system responses during sedative infusions of dexmedetomidine. Anesthesiology. 97:592–598. 2002. View Article : Google Scholar : PubMed/NCBI